Skip to main content

RT @uptoTate: CZP tx in axSpA pts showed significant reduction of 82% in the AAU flare rate and MSK symptoms over 96 wee

Social Author Name
Dr. Rachel Tate
Tweet Content
CZP tx in axSpA pts showed significant reduction of 82% in the AAU flare rate and MSK symptoms over 96 week C-VIEW trial. #ABS0881 #ACR20 @RheumNow https://t.co/bNFHXbKEuF https://t.co/3Z232vKGPC
Show on Archive Page
On
Display in Search Results
On